When It Comes to Weight Gain, Not All Antidepressants Are the Same
By Dennis Thompson HealthDay Reporter
WEDNESDAY, July 3, 2024 -- Weight gain is a common side effect of antidepressants, but some types cause people to pack on pounds more than others, a new study says.
Bupropion users are 15% to 20% less likely to gain a significant amount of weight than those taking the most common antidepressant, sertraline, researchers reported July 2 in the Annals of Internal Medicine.
At the same time, escitalopram and paroxetine had a 15% higher risk of gaining weight compared to sertraline, even though all are selective serotonin reuptake inhibitors (SSRIs), researchers found.
“Our study found that some antidepressants, like bupropion, are associated with less weight gain than others,” said senior researcher Dr. Jason Block, a general internal medicine physician at the Harvard Pilgrim Health Care Institute in Boston.
About 14% of U.S. adults use antidepressants, researchers said in background notes.
For the study, researchers analyzed data for more than 183,000 people ages 18 to 80 who were newly prescribed antidepressants. The team checked the patients’ weight at six months, one year and two years after they started taking one of eight common antidepressants.
Overall, bupropion users gained the least amount of weight compared to users of other antidepressants, researchers said.
A weight gain of about 5% or more was considered clinically significant.
“Although there are several reasons why patients and their clinicians might choose one antidepressant over another, weight gain is an important side effect that often leads to patients stopping their medication,” Block said in an institute news release. “Patients and their clinicians could consider weight gain as one reason for choosing a medication that best fits their needs.”
Sources
- Harvard Pilgrim Health Care Institute, news release, July 1, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2024
Read this next
FDA Will Now Require Labeling of ADHD Medication to Indicate Weight Loss Risk
WEDNESDAY, July 2, 2025 -- The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity disorder (ADHD) medications...
Sleep Apnea Puts Soldiers In Harm's Way
WEDNESDAY, July 2, 2025 — Sleep apnea could be increasing the risks borne by U.S. soldiers serving on the front lines of combat, a new study says. Front-line soldiers are...
Exercise Helps Kids' Mood Disorders, Can Serve As Alternative To Meds, Review Finds
MONDAY, June 30, 2025 — Regular exercise can ease mood disorders in children and teens, offering an alternative to medications like antidepressants, a new evidence review...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.